VFS VinFast Auto | $4.11 -9.9% | 5/13/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $13.00 -> $13.00 | Low | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 5/13/2024 |
CLSK CleanSpark | $15.36 -1.2% | 5/13/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $26.00 -> $26.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 5/13/2024 |
RNA Avidity Biosciences | $28.91 +11.1% | 5/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $33.00 -> $33.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 5/10/2024 |
PRQR ProQR Therapeutics | $1.99 +0.5% | 5/10/2024 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $2.50 -> $2.50 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 5/10/2024 |
ARWR Arrowhead Pharmaceuticals | $22.91 +3.9% | 5/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 -> $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/10/2024 |
PET Wag! Group | $2.27 +0.4% | 5/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 -> $8.00 | Low | View details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 5/10/2024 |
|
COYA Coya Therapeutics | $8.25 +2.1% | 5/9/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $14.00 -> $14.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 5/9/2024 |
VLN Valens Semiconductor | $2.45 +0.4% | 5/9/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 5/9/2024 |
SLDP Solid Power | $1.99 +5.9% | 5/8/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 -> $5.00 | Low | View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 5/8/2024 |
MCRB Seres Therapeutics | $0.90 -7.2% | 5/8/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $8.00 -> $6.00 | Low | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 5/8/2024 |
PLBY PLBY Group | $0.94
| 5/8/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 5/8/2024 |
MARA Marathon Digital | $18.07 +4.7% | 5/8/2024 | Target Lowered by | Chardan Capital | - | Neutral -> Neutral | $30.00 -> $21.00 | Low | View details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 5/8/2024 |
CLSK CleanSpark | $15.36 -1.2% | 5/7/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $26.00 -> $26.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 5/7/2024 |
OMGA Omega Therapeutics | $2.36
| 5/7/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 5/7/2024 |
EYPT EyePoint Pharmaceuticals | $12.45 +1.9% | 5/7/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $39.00 -> $28.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/7/2024 |
DYN Dyne Therapeutics | $28.16 +5.8% | 5/6/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $31.00 -> $31.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 5/6/2024 |
ABUS Arbutus Biopharma | $2.86 -1.0% | 5/3/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 5/3/2024 |
ALNY Alnylam Pharmaceuticals | $147.89 -1.3% | 5/3/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $225.00 -> $225.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 5/3/2024 |
COYA Coya Therapeutics | $8.25 +2.1% | 4/29/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $14.00 -> $14.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 4/29/2024 |
BMTX BM Technologies | $1.72 +1.2% | 4/22/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 -> $8.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 4/22/2024 |
OCGN Ocugen | $1.70 -6.1% | 4/22/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $4.00 -> $5.00 | Low | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 4/22/2024 |
PRME Prime Medicine | $6.66 +3.7% | 4/22/2024 | Initiated by | Chardan Capital | - | Buy | $17.00 | Low | View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 4/22/2024 |
LICY Li-Cycle | $0.60
| 4/19/2024 | Reiterated by | Chardan Capital | - | Neutral -> Neutral | $0.75 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 4/19/2024 |
VFS VinFast Auto | $4.11 -9.9% | 4/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $13.00 | Low | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 4/18/2024 |
DFLI Dragonfly Energy | $1.23 +3.4% | 4/16/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $3.00 | Low | View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 4/16/2024 |
SABS SAB Biotherapeutics | $4.05 -1.0% | 4/16/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $25.00 | Low | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/16/2024 |
VFS VinFast Auto | $4.11 -9.9% | 4/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $13.00 | Low | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 4/10/2024 |
NRGV Energy Vault | $1.24 +11.7% | 4/8/2024 | Reiterated by | Chardan Capital | - | Buy -> Sell | $7.00 -> $0.75 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 4/8/2024 |
ACHL Achilles Therapeutics | $0.92 +3.4% | 4/5/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $11.00 -> $6.00 | Low | View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 4/5/2024 |
BMTX BM Technologies | $1.72 +1.2% | 4/4/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 4/4/2024 |
ALUR Allurion Technologies | $2.03 +4.6% | 4/4/2024 | Initiated by | Chardan Capital | - | Buy | $5.00 | Low | View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 4/4/2024 |
OUST Ouster | $11.98 -3.7% | 4/3/2024 | Reiterated by | Chardan Capital | - | Buy -> Neutral | $10.00 | Low | View details for Chardan Capital rating of Ouster (NYSE:OUST) on 4/3/2024 |
SABS SAB Biotherapeutics | $4.05 -1.0% | 4/2/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $3.00 -> $25.00 | Low | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/2/2024 |
FEMY Femasys | $1.38 +8.7% | 4/1/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $12.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 4/1/2024 |
OMGA Omega Therapeutics | $2.36
| 4/1/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $12.00 -> $7.00 | Low | View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 4/1/2024 |
OBIO Orchestra BioMed | $5.20 +13.0% | 3/28/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 3/28/2024 |
MGX Metagenomi | $6.54 -0.2% | 3/28/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $21.00 | Low | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 3/28/2024 |
GANX Gain Therapeutics | $2.34 -3.3% | 3/27/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 | Low | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 3/27/2024 |
PLBY PLBY Group | $0.94
| 3/26/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 | Low | View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 3/26/2024 |
TNYA Tenaya Therapeutics | $4.40 +2.8% | 3/21/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/21/2024 |
HUGE BUY ALERT: Move Fast, Musk... (Ad) I recently traveled to Phoenix, Arizona...And based on what I saw out there, I'm prepared to put my reputation on the line.
Since 2018, my investment recommendations have averaged 115% per year.
But one investment I've just discovered could blow them all away. You won't believe what I saw in Phoenix. |
FEMY Femasys | $1.38 +8.7% | 3/21/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $12.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 3/21/2024 |
TSHA Taysha Gene Therapies | $2.57 +7.1% | 3/21/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $5.00 -> $7.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/21/2024 |
COYA Coya Therapeutics | $8.25 +2.1% | 3/20/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $11.00 -> $14.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/20/2024 |
OCS Oculis | $12.16 +0.7% | 3/19/2024 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy -> Buy | $30.00 | Low | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 3/19/2024 |
ADVM Adverum Biotechnologies | $8.93 -2.6% | 3/19/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 | Low | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 3/19/2024 |
PRQR ProQR Therapeutics | $1.99 +0.5% | 3/14/2024 | Target Raised by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $2.00 -> $2.50 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2024 |
SLN Silence Therapeutics | $21.14 +1.5% | 3/14/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $26.00 -> $42.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 3/14/2024 |
IMRX Immuneering | $1.60 +0.6% | 3/15/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $21.00 -> $16.00 | N/A | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 3/15/2024 |
GWH ESS Tech | $0.80 +5.3% | 3/15/2024 | Target Lowered by | Chardan Capital | - | Neutral -> Neutral | $1.90 -> $0.80 | N/A | View details for Chardan Capital rating of ESS Tech (NYSE:GWH) on 3/15/2024 |
NRGV Energy Vault | $1.24 +11.7% | 3/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 3/18/2024 |
DYN Dyne Therapeutics | $28.16 +5.8% | 3/8/2024 | Target Raised by | Chardan Capital | - | Buy | $20.00 -> $31.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/8/2024 |
RGNX REGENXBIO | $15.80 +0.4% | 3/7/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $52.00 | Low | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/7/2024 |
MCRB Seres Therapeutics | $0.90 -7.2% | 3/6/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $10.00 -> $8.00 | Low | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024 |
MGX Metagenomi | $6.54 -0.2% | 3/5/2024 | Initiated by | Chardan Capital | - | Buy | $21.00 | Low | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 3/5/2024 |
MARA Marathon Digital | $18.07 +4.7% | 3/4/2024 | Target Raised by | Chardan Capital | - | Neutral -> Neutral | $26.00 -> $30.00 | Low | View details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 3/4/2024 |
CLSK CleanSpark | $15.36 -1.2% | 3/4/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $13.00 -> $26.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 3/4/2024 |
ABUS Arbutus Biopharma | $2.86 -1.0% | 3/1/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 3/1/2024 |
RNA Avidity Biosciences | $28.91 +11.1% | 2/29/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $23.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 2/29/2024 |
VFS VinFast Auto | $4.11 -9.9% | 2/28/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $11.00 -> $13.00 | Low | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 2/28/2024 |
SLDP Solid Power | $1.99 +5.9% | 2/28/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 | Low | View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 2/28/2024 |
CRSP CRISPR Therapeutics | $55.71 +0.1% | 2/22/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $110.00 -> $112.00 | Low | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/22/2024 |
IOVA Iovance Biotherapeutics | $10.72 -1.5% | 2/20/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $29.00 -> $34.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 2/20/2024 |
ALNY Alnylam Pharmaceuticals | $147.89 -1.3% | 2/16/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $250.00 -> $225.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/16/2024 |
OTLK Outlook Therapeutics | $7.40 -1.9% | 2/15/2024 | Upgraded by | Chardan Capital | Analyst D. Gataulin | Neutral -> Buy | $60.00 | Low | View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 2/15/2024 |
SYBX Synlogic | $1.75 -2.8% | 2/9/2024 | Downgraded by | Chardan Capital | Analyst K. Nakae | Buy -> Neutral | | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 2/9/2024 |
OCS Oculis | $12.16 +0.7% | 12/5/2023 | Initiated by | Chardan Capital | Analyst D. Gataulin | Buy | $30.00 | Low | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 12/5/2023 |
LXEO Lexeo Therapeutics | $13.97 +3.0% | 11/28/2023 | Initiated by | Chardan Capital | Analyst G. Livshits | Buy | $23.00 | Low | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/28/2023 |
LICY Li-Cycle | $0.60
| 11/16/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 11/16/2023 |
PRQR ProQR Therapeutics | $1.99 +0.5% | 11/8/2023 | Upgraded by | Chardan Capital | Analyst K. Nakae | Neutral -> Buy | $2.00 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 11/8/2023 |
WBX Wallbox | $1.47 +3.5% | 10/19/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | $2.25 | Low | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 10/19/2023 |
VFS VinFast Auto | $4.11 -9.9% | 10/10/2023 | Initiated by | Chardan Capital | - | Buy | | Low | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 10/10/2023 |
VYGR Voyager Therapeutics | $8.48
| 9/18/2023 | Reiterated by | Chardan Capital | Analyst G. Livshits | Neutral | | Low | View details for Chardan Capital rating of Voyager Therapeutics (NASDAQ:VYGR) on 9/18/2023 |
OTLK Outlook Therapeutics | $7.40 -1.9% | 8/31/2023 | Downgraded by | Chardan Capital | Analyst D. Gataulin | Buy -> Neutral | | Low | View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/31/2023 |
ZURA Zura Bio | $5.16 +7.7% | 8/17/2023 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy | | Low | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 8/17/2023 |
QURE uniQure | $4.91 +0.6% | 8/17/2023 | Reiterated by | Chardan Capital | Analyst Y. Livshits | Buy | | Low | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 8/17/2023 |
PPBT Purple Biotech | $0.53 +1.9% | 8/17/2023 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy | | Low | View details for Chardan Capital rating of Purple Biotech (NASDAQ:PPBT) on 8/17/2023 |
PLBY PLBY Group | $0.94
| 8/17/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $5.00 -> $4.00 | Low | View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 8/17/2023 |
SLN Silence Therapeutics | $21.14 +1.5% | 8/17/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $26.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 8/17/2023 |
IOVA Iovance Biotherapeutics | $10.72 -1.5% | 8/16/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $29.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/16/2023 |
LICY Li-Cycle | $0.60
| 8/16/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $8.00 -> $7.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 8/16/2023 |
VLN Valens Semiconductor | $2.45 +0.4% | 8/15/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $9.00 -> $5.00 | Low | View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 8/15/2023 |
SNTI Senti Biosciences | $0.38 +2.7% | 8/15/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 | Low | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 8/15/2023 |
OTLK Outlook Therapeutics | $7.40 -1.9% | 8/15/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $200.00 | Low | View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/15/2023 |
TSHA Taysha Gene Therapies | $2.57 +7.1% | 8/15/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 8/15/2023 |
TNYA Tenaya Therapeutics | $4.40 +2.8% | 8/14/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $23.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 8/14/2023 |
GANX Gain Therapeutics | $2.34 -3.3% | 8/14/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 | Low | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 8/14/2023 |
SYBX Synlogic | $1.75 -2.8% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $90.00 | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 8/11/2023 |
CLSK CleanSpark | $15.36 -1.2% | 8/11/2023 | Target Raised by | Chardan Capital | - | Buy -> Buy | $10.00 -> $11.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 8/11/2023 |
MGTX MeiraGTx | $5.23 +1.8% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $41.00 | Low | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 8/11/2023 |
FDMT 4D Molecular Therapeutics | $25.75 +0.7% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $31.00 | Low | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 8/11/2023 |
America could fall from this event (Ad) America’s “Internal Enemies” Exposed
New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash. Click here to see how you can protect yourself today. |
RCKT Rocket Pharmaceuticals | $23.38 +1.3% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $61.00 | Low | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/11/2023 |
FEMY Femasys | $1.38 +8.7% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $10.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 8/11/2023 |
ADVM Adverum Biotechnologies | $8.93 -2.6% | 8/11/2023 | Upgraded by | Chardan Capital | Analyst D. Gataulin | Neutral -> Buy | $20.00 -> $40.00 | Low | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 8/11/2023 |
OBIO Orchestra BioMed | $5.20 +13.0% | 8/9/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 8/9/2023 |
COYA Coya Therapeutics | $8.25 +2.1% | 8/9/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $11.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 8/9/2023 |
NRGV Energy Vault | $1.24 +11.7% | 8/9/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 8/9/2023 |
IOVA Iovance Biotherapeutics | $10.72 -1.5% | 8/9/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $29.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/9/2023 |
PET Wag! Group | $2.27 +0.4% | 8/10/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 | N/A | View details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 8/10/2023 |
SLDP Solid Power | $1.99 +5.9% | 8/10/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 | N/A | View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 8/10/2023 |
IPSC Century Therapeutics | $3.15 +5.0% | 8/9/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $19.00 -> $17.00 | Low | View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 8/9/2023 |
RNA Avidity Biosciences | $28.91 +11.1% | 8/9/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $27.00 -> $23.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 8/9/2023 |
ARWR Arrowhead Pharmaceuticals | $22.91 +3.9% | 8/8/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 8/8/2023 |
ALNY Alnylam Pharmaceuticals | $147.89 -1.3% | 8/8/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $250.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 8/8/2023 |
CRSP CRISPR Therapeutics | $55.71 +0.1% | 8/7/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $123.00 -> $110.00 | Low | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/7/2023 |
KRYS Krystal Biotech | $159.47 +3.0% | 8/7/2023 | Target Raised by | Chardan Capital | - | Buy -> Buy | $148.00 -> $153.00 | Low | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/7/2023 |
PASG Passage Bio | $1.33 -10.8% | 8/7/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $11.00 -> $9.00 | Low | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 8/7/2023 |
MARA Marathon Digital | $18.07 +4.7% | 8/7/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | $15.00 | Low | View details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 8/7/2023 |
NTLA Intellia Therapeutics | $25.73 +1.2% | 8/7/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $107.00 | Low | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 8/7/2023 |
ACHL Achilles Therapeutics | $0.92 +3.4% | 8/7/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $11.00 | Low | View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 8/7/2023 |
IMRX Immuneering | $1.60 +0.6% | 8/7/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $22.00 | Low | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/7/2023 |
ABUS Arbutus Biopharma | $2.86 -1.0% | 8/4/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 8/4/2023 |
DYN Dyne Therapeutics | $28.16 +5.8% | 8/4/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 8/4/2023 |
OMGA Omega Therapeutics | $2.36
| 8/4/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $12.00 | Low | View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 8/4/2023 |
PRQR ProQR Therapeutics | $1.99 +0.5% | 8/4/2023 | Reiterated by | Chardan Capital | - | Neutral -> Neutral | $2.00 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 8/4/2023 |
MESO Mesoblast | $7.20 +3.2% | 8/4/2023 | Target Lowered by | Chardan Capital | - | Sell -> Sell | $4.00 -> $3.00 | Low | View details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 8/4/2023 |
RGNX REGENXBIO | $15.80 +0.4% | 8/3/2023 | Reiterated by | Chardan Capital | - | Buy | $55.00 | Low | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 8/3/2023 |
EYPT EyePoint Pharmaceuticals | $12.45 +1.9% | 8/3/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $22.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 8/3/2023 |
EDIT Editas Medicine | $5.68 -0.5% | 8/2/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $22.00 -> $19.00 | Low | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 8/2/2023 |
NRGV Energy Vault | $1.24 +11.7% | 8/2/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 8/2/2023 |
LICY Li-Cycle | $0.60
| 8/1/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 8/1/2023 |
BMTX BM Technologies | $1.72 +1.2% | 7/26/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $8.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 7/26/2023 |
KOD Kodiak Sciences | $3.84 +0.3% | 7/25/2023 | Downgraded by | Chardan Capital | Analyst D. Gataulin | Buy -> Neutral | | Low | View details for Chardan Capital rating of Kodiak Sciences (NASDAQ:KOD) on 7/25/2023 |
CLSK CleanSpark | $15.36 -1.2% | 7/24/2023 | Target Raised by | Chardan Capital | - | Buy | $6.00 -> $10.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 7/24/2023 |
FBRX Forte Biosciences | $0.68 -4.2% | 7/16/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Neutral | | Low | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 7/16/2023 |
DFLI Dragonfly Energy | $1.23 +3.4% | 7/13/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $10.00 | Low | View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 7/13/2023 |
OUST Ouster | $11.98 -3.7% | 7/13/2023 | Upgraded by | Chardan Capital | - | Neutral -> Buy | $10.00 | Low | View details for Chardan Capital rating of Ouster (NYSE:OUST) on 7/13/2023 |
WBX Wallbox | $1.47 +3.5% | 6/30/2023 | Target Lowered by | Chardan Capital | - | Buy | $12.00 -> $11.00 | Low | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 6/30/2023 |
ZURA Zura Bio | $5.16 +7.7% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 7/10/2023 |
XLO Xilio Therapeutics | $1.09 -2.7% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Xilio Therapeutics (NASDAQ:XLO) on 7/10/2023 |
QURE uniQure | $4.91 +0.6% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 7/10/2023 |
PPBT Purple Biotech | $0.53 +1.9% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Purple Biotech (NASDAQ:PPBT) on 7/10/2023 |
IMVT Immunovant | $30.48 +2.0% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 7/10/2023 |
IMNM Immunome | $14.72 -5.7% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Immunome (NASDAQ:IMNM) on 7/10/2023 |
FDMT 4D Molecular Therapeutics | $25.75 +0.7% | 7/11/2023 | Target Raised by | Chardan Capital | - | | $30.00 -> $31.00 | Low | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/11/2023 |
FDMT 4D Molecular Therapeutics | $25.75 +0.7% | 7/5/2023 | Initiated by | Chardan Capital | - | Buy | $30.00 | Low | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/5/2023 |
ZURA Zura Bio | $5.16 +7.7% | 6/14/2023 | Initiated by | Chardan Capital | Analyst M. Barcus | Buy | $14.00 | Low | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 6/14/2023 |
NTLA Intellia Therapeutics | $25.73 +1.2% | 6/13/2023 | Target Lowered by | Chardan Capital | - | | $111.00 -> $107.00 | Low | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/13/2023 |
COYA Coya Therapeutics | $8.25 +2.1% | 6/7/2023 | Target Raised by | Chardan Capital | Analyst K. Nakae | | $9.00 -> $11.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 6/7/2023 |
SYBX Synlogic | $1.75 -2.8% | 6/6/2023 | Target Raised by | Chardan Capital | - | | $82.50 -> $90.00 | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 6/6/2023 |
PRST Presto Automation | $0.16 -6.0% | 6/1/2023 | Upgraded by | Chardan Capital | - | Neutral -> Buy | $4.25 -> $5.00 | N/A | View details for Chardan Capital rating of Presto Automation (NASDAQ:PRST) on 6/1/2023 |
Biden to Drop BOMBSHELL June 13th? (Ad) Biden’s days are numbered!
According to a former CIA and Pentagon insider…
He’s about to drop out of the presidential race on June 13th! Click here now to see his shocking evidence. |
MESO Mesoblast | $7.20 +3.2% | 5/30/2023 | Target Lowered by | Chardan Capital | - | | $5.00 -> $4.00 | Low | View details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 5/30/2023 |
IMVT Immunovant | $30.48 +2.0% | 5/22/2023 | Target Raised by | Chardan Capital | - | | $21.00 -> $32.00 | Low | View details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 5/22/2023 |
KRYS Krystal Biotech | $159.47 +3.0% | 5/22/2023 | Target Raised by | Chardan Capital | - | | $133.00 -> $148.00 | Low | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 5/22/2023 |
EYPT EyePoint Pharmaceuticals | $12.45 +1.9% | 5/18/2023 | Target Raised by | Chardan Capital | - | | $21.00 -> $22.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/18/2023 |
FBRX Forte Biosciences | $0.68 -4.2% | 5/15/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Neutral | | Low | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 5/15/2023 |
KITT Nauticus Robotics | $0.17 +21.8% | 5/12/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | $2.50 | Low | View details for Chardan Capital rating of Nauticus Robotics (NASDAQ:KITT) on 5/12/2023 |
TNYA Tenaya Therapeutics | $4.40 +2.8% | 5/11/2023 | Target Lowered by | Chardan Capital | - | | $24.00 -> $23.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 5/11/2023 |
VLN Valens Semiconductor | $2.45 +0.4% | 5/11/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $12.00 | Low | View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 5/11/2023 |
QURE uniQure | $4.91 +0.6% | 5/10/2023 | Target Lowered by | Chardan Capital | - | | $60.00 -> $56.00 | Low | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 5/10/2023 |
OCGN Ocugen | $1.70 -6.1% | 5/7/2023 | Target Raised by | Chardan Capital | Analyst D. Gataulin | | $3.50 -> $4.00 | Low | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 5/7/2023 |
RCKT Rocket Pharmaceuticals | $23.38 +1.3% | 5/5/2023 | Target Lowered by | Chardan Capital | - | | $63.00 -> $61.00 | Low | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/5/2023 |
RGNX REGENXBIO | $15.80 +0.4% | 5/4/2023 | Target Lowered by | Chardan Capital | - | | $61.00 -> $55.00 | Low | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 5/4/2023 |
MCRB Seres Therapeutics | $0.90 -7.2% | 4/28/2023 | Target Lowered by | Chardan Capital | - | | $12.00 -> $10.00 | Low | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 4/28/2023 |
WBX Wallbox | $1.47 +3.5% | 4/18/2023 | Reiterated by | Chardan Capital | - | Buy | $12.00 | Low | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 4/18/2023 |
IMRX Immuneering | $1.60 +0.6% | 4/18/2023 | Target Raised by | Chardan Capital | - | Buy | $18.00 -> $22.00 | Low | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 4/18/2023 |
OCGN Ocugen | $1.70 -6.1% | 4/14/2023 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy | $3.50 | Low | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 4/14/2023 |
CLSK CleanSpark | $15.36 -1.2% | 4/17/2023 | Reiterated by | Chardan Capital | - | Buy | $5.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 4/17/2023 |
MARA Marathon Digital | $18.07 +4.7% | 4/3/2023 | Reiterated by | Chardan Capital | - | Buy | $15.00 | Low | View details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 4/3/2023 |
COYA Coya Therapeutics | $8.25 +2.1% | 3/30/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy | $9.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/30/2023 |
RNA Avidity Biosciences | $28.91 +11.1% | 3/31/2023 | Reiterated by | Chardan Capital | - | Buy | $27.00 | N/A | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 3/31/2023 |
FEMY Femasys | $1.38 +8.7% | 3/30/2023 | Target Lowered by | Chardan Capital | - | Buy | $12.00 -> $10.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 3/30/2023 |
TSHA Taysha Gene Therapies | $2.57 +7.1% | 3/29/2023 | Target Lowered by | Chardan Capital | - | Buy | $6.00 -> $5.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/29/2023 |
SYBX Synlogic | $1.75 -2.8% | 3/29/2023 | Target Lowered by | Chardan Capital | - | Buy | $105.00 -> $82.50 | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 3/29/2023 |
PRST Presto Automation | $0.16 -6.0% | 3/28/2023 | Reiterated by | Chardan Capital | - | Neutral | $4.25 | N/A | View details for Chardan Capital rating of Presto Automation (NASDAQ:PRST) on 3/28/2023 |
MARA Marathon Digital | $18.07 +4.7% | 3/28/2023 | Target Lowered by | Chardan Capital | - | Buy | $17.00 -> $15.00 | Low | View details for Chardan Capital rating of Marathon Digital (NASDAQ:MARA) on 3/28/2023 |
BMTX BM Technologies | $1.72 +1.2% | 3/29/2023 | Reiterated by | Chardan Capital | - | Buy | $13.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 3/29/2023 |
GANX Gain Therapeutics | $2.34 -3.3% | 3/27/2023 | Target Raised by | Chardan Capital | - | | $4.00 -> $5.75 | Low | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 3/27/2023 |
OUST Ouster | $11.98 -3.7% | 3/24/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | $10.00 | Low | View details for Chardan Capital rating of Ouster (NYSE:OUST) on 3/24/2023 |
SNTI Senti Biosciences | $0.38 +2.7% | 3/23/2023 | Target Lowered by | Chardan Capital | - | Buy | $8.00 -> $7.00 | Low | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 3/23/2023 |
IMTX Immatics | $11.60 +5.5% | 3/23/2023 | Target Lowered by | Chardan Capital | - | Buy | $28.00 -> $25.00 | Low | View details for Chardan Capital rating of Immatics (NASDAQ:IMTX) on 3/23/2023 |
COYA Coya Therapeutics | $8.25 +2.1% | 3/22/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy | $9.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/22/2023 |
ANIX Anixa Biosciences | $2.98 +0.3% | 3/22/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | $8.00 -> $9.00 | Low | View details for Chardan Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 3/22/2023 |
CABA Cabaletta Bio | $11.23 -0.3% | 3/22/2023 | Reiterated by | Chardan Capital | - | Buy | $12.00 | Low | View details for Chardan Capital rating of Cabaletta Bio (NASDAQ:CABA) on 3/22/2023 |
IPSC Century Therapeutics | $3.15 +5.0% | 3/22/2023 | Reiterated by | Chardan Capital | Analyst G. Livshits | Buy | $19.00 | Low | View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 3/22/2023 |
IMNM Immunome | $14.72 -5.7% | 3/16/2023 | Target Lowered by | Chardan Capital | - | Buy | $9.00 -> $8.00 | Low | View details for Chardan Capital rating of Immunome (NASDAQ:IMNM) on 3/16/2023 |
CRGO Freightos | $2.22 +0.5% | 3/16/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $11.00 | Low | View details for Chardan Capital rating of Freightos (NASDAQ:CRGO) on 3/16/2023 |
MGTX MeiraGTx | $5.23 +1.8% | 3/16/2023 | Target Lowered by | Chardan Capital | - | Buy | $47.00 -> $41.00 | Low | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 3/16/2023 |
SLN Silence Therapeutics | $21.14 +1.5% | 3/16/2023 | Target Lowered by | Chardan Capital | - | Buy | $29.00 -> $26.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 3/16/2023 |
NRGV Energy Vault | $1.24 +11.7% | 3/9/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $7.00 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 3/9/2023 |
TNYA Tenaya Therapeutics | $4.40 +2.8% | 3/9/2023 | Target Lowered by | Chardan Capital | - | Buy | $28.00 -> $24.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/9/2023 |
MCRB Seres Therapeutics | $0.90 -7.2% | 3/8/2023 | Reiterated by | Chardan Capital | - | Buy | $12.00 | Low | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 3/8/2023 |
ACHL Achilles Therapeutics | $0.92 +3.4% | 3/8/2023 | Target Lowered by | Chardan Capital | - | | $17.00 -> $12.00 | Low | View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 3/8/2023 |
IMRX Immuneering | $1.60 +0.6% | 3/7/2023 | Reiterated by | Chardan Capital | - | Buy | $18.00 | N/A | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 3/7/2023 |
EYPT EyePoint Pharmaceuticals | $12.45 +1.9% | 3/3/2023 | Reiterated by | Chardan Capital | - | Buy | $21.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 3/3/2023 |
GWH ESS Tech | $0.80 +5.3% | 3/3/2023 | Target Lowered by | Chardan Capital | - | Neutral | $4.50 -> $1.80 | Low | View details for Chardan Capital rating of ESS Tech (NYSE:GWH) on 3/3/2023 |
VLN Valens Semiconductor | $2.45 +0.4% | 3/3/2023 | Reiterated by | Chardan Capital | - | Buy | $13.00 | Low | View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 3/3/2023 |
ABUS Arbutus Biopharma | $2.86 -1.0% | 3/3/2023 | Reiterated by | Chardan Capital | - | Buy | $6.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 3/3/2023 |
DYN Dyne Therapeutics | $28.16 +5.8% | 3/3/2023 | Target Raised by | Chardan Capital | - | Buy | $17.00 -> $20.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/3/2023 |
RGNX REGENXBIO | $15.80 +0.4% | 3/2/2023 | Reiterated by | Chardan Capital | - | Buy | $61.00 | Low | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/2/2023 |
IOVA Iovance Biotherapeutics | $10.72 -1.5% | 3/1/2023 | Reiterated by | Chardan Capital | Analyst Geulah Livshits | Buy | $29.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 3/1/2023 |
Biden to Drop BOMBSHELL June 13th? (Ad) Biden’s days are numbered!
According to a former CIA and Pentagon insider…
He’s about to drop out of the presidential race on June 13th! Click here now to see his shocking evidence. |
MESO Mesoblast | $7.20 +3.2% | 3/1/2023 | Reiterated by | Chardan Capital | - | Sell | $5.00 | Low | View details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 3/1/2023 |
RNA Avidity Biosciences | $28.91 +11.1% | 3/1/2023 | Reiterated by | Chardan Capital | - | Buy | $27.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 3/1/2023 |
OCGN Ocugen | $1.70 -6.1% | 3/1/2023 | Upgraded by | Chardan Capital | Analyst D. Gataulin | Neutral -> Buy | $3.50 | Low | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 3/1/2023 |
RCKT Rocket Pharmaceuticals | $23.38 +1.3% | 3/1/2023 | Target Lowered by | Chardan Capital | - | Buy | $65.00 -> $63.00 | Low | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 3/1/2023 |
KRYS Krystal Biotech | $159.47 +3.0% | 2/28/2023 | Reiterated by | Chardan Capital | - | Buy | $133.00 | Low | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 2/28/2023 |
QURE uniQure | $4.91 +0.6% | 2/28/2023 | Reiterated by | Chardan Capital | - | Buy | $60.00 | Low | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 2/28/2023 |
LICY Li-Cycle | $0.60
| 2/28/2023 | Reiterated by | Chardan Capital | - | Buy | $10.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 2/28/2023 |
CRGO Freightos | $2.22 +0.5% | 2/28/2023 | Reiterated by | Chardan Capital | - | Buy | | Low | View details for Chardan Capital rating of Freightos (NASDAQ:CRGO) on 2/28/2023 |
NTLA Intellia Therapeutics | $25.73 +1.2% | 2/24/2023 | Target Lowered by | Chardan Capital | Analyst Geulah Livshits | Buy | $129.00 -> $111.00 | Low | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 2/24/2023 |
WBX Wallbox | $1.47 +3.5% | 2/24/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $12.00 | Low | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 2/24/2023 |
ALNY Alnylam Pharmaceuticals | $147.89 -1.3% | 2/24/2023 | Reiterated by | Chardan Capital | - | Buy | $250.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/24/2023 |
EDIT Editas Medicine | $5.68 -0.5% | 2/23/2023 | Target Lowered by | Chardan Capital | - | Buy | $35.00 -> $22.00 | Low | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 2/23/2023 |
PET Wag! Group | $2.27 +0.4% | 2/22/2023 | Target Raised by | Chardan Capital | - | Buy | $5.00 -> $8.00 | Low | View details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 2/22/2023 |
CRSP CRISPR Therapeutics | $55.71 +0.1% | 2/22/2023 | Target Lowered by | Chardan Capital | - | Buy | $153.00 -> $123.00 | Low | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/22/2023 |
PRST Presto Automation | $0.16 -6.0% | 2/16/2023 | Reiterated by | Chardan Capital | - | Neutral | $4.25 | N/A | View details for Chardan Capital rating of Presto Automation (NASDAQ:PRST) on 2/16/2023 |
PLBY PLBY Group | $0.94
| 2/13/2023 | Reiterated by | Chardan Capital | - | Buy | $5.00 | Low | View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 2/13/2023 |
DFLI Dragonfly Energy | $1.23 +3.4% | 2/10/2023 | Target Lowered by | Chardan Capital | - | Buy | $15.00 -> $10.00 | Low | View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 2/10/2023 |
ARWR Arrowhead Pharmaceuticals | $22.91 +3.9% | 2/10/2023 | Reiterated by | Chardan Capital | - | Buy | $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 2/10/2023 |
PPBT Purple Biotech | $0.53 +1.9% | 2/9/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | $11.00 | Low | View details for Chardan Capital rating of Purple Biotech (NASDAQ:PPBT) on 2/9/2023 |
BMTX BM Technologies | $1.72 +1.2% | 2/7/2023 | Target Lowered by | Chardan Capital | - | Buy | $21.00 -> $13.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 2/7/2023 |
OBIO Orchestra BioMed | $5.20 +13.0% | 2/7/2023 | Initiated by | Chardan Capital | Analyst K. Nakae | Buy | $20.00 | Low | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 2/7/2023 |
IMVT Immunovant | $30.48 +2.0% | 2/5/2023 | Target Raised by | Chardan Capital | - | Buy | $19.00 -> $21.00 | Low | View details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 2/5/2023 |
TSHA Taysha Gene Therapies | $2.57 +7.1% | 2/1/2023 | Target Lowered by | Chardan Capital | - | Buy | $16.00 -> $6.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 2/1/2023 |
LICY Li-Cycle | $0.60
| 1/31/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $10.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 1/31/2023 |
SNTI Senti Biosciences | $0.38 +2.7% | 1/27/2023 | Target Lowered by | Chardan Capital | - | Buy | $12.00 -> $8.00 | Low | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 1/27/2023 |
COYA Coya Therapeutics | $8.25 +2.1% | 1/26/2023 | Initiated by | Chardan Capital | Analyst K. Nakae | Buy | $9.00 | N/A | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 1/26/2023 |
MRNA Moderna | $128.32 +2.1% | 1/18/2023 | Target Raised by | Chardan Capital | Analyst Y. Livshits | Neutral | $191.00 -> $208.00 | Low | View details for Chardan Capital rating of Moderna (NASDAQ:MRNA) on 1/18/2023 |
ARWR Arrowhead Pharmaceuticals | $22.91 +3.9% | 1/10/2023 | Target Lowered by | Chardan Capital | - | | $82.00 -> $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 1/10/2023 |
IPSC Century Therapeutics | $3.15 +5.0% | 12/27/2022 | Initiated by | Chardan Capital | Analyst G. Livshits | Buy | $19.00 | Low | View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 12/27/2022 |
ANIX Anixa Biosciences | $2.98 +0.3% | 12/23/2022 | Initiated by | Chardan Capital | - | Buy | $8.00 | Low | View details for Chardan Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 12/23/2022 |
XLO Xilio Therapeutics | $1.09 -2.7% | 12/21/2022 | Initiated by | Chardan Capital | Analyst M. Barcus | Buy | $7.00 | Low | View details for Chardan Capital rating of Xilio Therapeutics (NASDAQ:XLO) on 12/21/2022 |
CLSK CleanSpark | $15.36 -1.2% | 12/15/2022 | Target Lowered by | Chardan Capital | - | Buy | $6.00 -> $5.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 12/15/2022 |
PASG Passage Bio | $1.33 -10.8% | 12/15/2022 | Target Lowered by | Chardan Capital | - | Buy | $18.00 -> $11.00 | Low | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 12/15/2022 |
MRNA Moderna | $128.32 +2.1% | 12/14/2022 | Downgraded by | Chardan Capital | Analyst Y. Livshits | Buy -> Neutral | $186.00 -> $191.00 | Low | View details for Chardan Capital rating of Moderna (NASDAQ:MRNA) on 12/14/2022 |
PRST Presto Automation | $0.16 -6.0% | 12/9/2022 | Initiated by | Chardan Capital | - | Neutral | $4.25 | N/A | View details for Chardan Capital rating of Presto Automation (NASDAQ:PRST) on 12/9/2022 |
GANX Gain Therapeutics | $2.34 -3.3% | 12/9/2022 | Initiated by | Chardan Capital | - | Buy | $4.00 | Low | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 12/9/2022 |
ACHL Achilles Therapeutics | $0.92 +3.4% | 12/6/2022 | Target Lowered by | Chardan Capital | - | Buy | $20.00 -> $17.00 | Low | View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 12/6/2022 |
IOVA Iovance Biotherapeutics | $10.72 -1.5% | 11/18/2022 | Target Lowered by | Chardan Capital | - | Buy | $30.00 -> $29.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 11/18/2022 |
DFLI Dragonfly Energy | $1.23 +3.4% | 11/18/2022 | Initiated by | Chardan Capital | - | Buy | $15.00 | Low | View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 11/18/2022 |
EDIT Editas Medicine | $5.68 -0.5% | 11/17/2022 | Target Lowered by | Chardan Capital | - | Buy | $43.00 -> $35.00 | Low | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 11/17/2022 |
SLN Silence Therapeutics | $21.14 +1.5% | 11/17/2022 | Target Lowered by | Chardan Capital | - | Buy | $33.00 -> $29.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 11/17/2022 |
VINC Vincerx Pharma | $0.76
| 11/16/2022 | Target Lowered by | Chardan Capital | - | Buy | $4.00 -> $3.00 | Low | View details for Chardan Capital rating of Vincerx Pharma (NASDAQ:VINC) on 11/16/2022 |
PDSB PDS Biotechnology | $3.54 -1.4% | 11/14/2022 | Target Raised by | Chardan Capital | - | Buy | $15.00 -> $16.00 | Low | View details for Chardan Capital rating of PDS Biotechnology (NASDAQ:PDSB) on 11/14/2022 |
NTLA Intellia Therapeutics | $25.73 +1.2% | 11/14/2022 | Target Raised by | Chardan Capital | Analyst Geulah Livshits | Buy | $121.00 -> $129.00 | Low | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/14/2022 |
CABA Cabaletta Bio | $11.23 -0.3% | 11/11/2022 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $12.00 | Low | View details for Chardan Capital rating of Cabaletta Bio (NASDAQ:CABA) on 11/11/2022 |
ADVM Adverum Biotechnologies | $8.93 -2.6% | 11/11/2022 | Target Lowered by | Chardan Capital | - | Neutral | $25.00 -> $20.00 | Low | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 11/11/2022 |
TNYA Tenaya Therapeutics | $4.40 +2.8% | 11/11/2022 | Target Lowered by | Chardan Capital | - | Buy | $30.00 -> $28.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 11/11/2022 |
SYBX Synlogic | $1.75 -2.8% | 11/11/2022 | Target Lowered by | Chardan Capital | Analyst Keay Nakae | Buy | $135.00 -> $105.00 | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 11/11/2022 |
FEMY Femasys | $1.38 +8.7% | 11/11/2022 | Target Lowered by | Chardan Capital | - | Buy | $15.00 -> $12.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 11/11/2022 |
PHGE BiomX | $0.35 +3.0% | 11/9/2022 | Target Lowered by | Chardan Capital | - | Buy | $6.00 -> $2.00 | N/A | View details for Chardan Capital rating of BiomX (NYSEMKT:PHGE) on 11/9/2022 |
TSHA Taysha Gene Therapies | $2.57 +7.1% | 11/9/2022 | Target Lowered by | Chardan Capital | - | Buy | $32.00 -> $16.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 11/9/2022 |
EBS Emergent BioSolutions | $5.08 -5.2% | 11/9/2022 | Target Lowered by | Chardan Capital | - | Buy | $65.00 -> $55.00 | Low | View details for Chardan Capital rating of Emergent BioSolutions (NYSE:EBS) on 11/9/2022 |
VTRS Viatris | $11.14 -1.9% | 11/7/2022 | Downgraded by | Chardan Capital | - | Buy -> Neutral | | N/A | View details for Chardan Capital rating of Viatris (NASDAQ:VTRS) on 11/7/2022 |
KRYS Krystal Biotech | $159.47 +3.0% | 11/7/2022 | Target Raised by | Chardan Capital | - | Buy | $130.00 -> $133.00 | Low | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 11/7/2022 |
IMVT Immunovant | $30.48 +2.0% | 11/7/2022 | Target Raised by | Chardan Capital | - | Buy | $12.00 -> $19.00 | Low | View details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 11/7/2022 |
MRNA Moderna | $128.32 +2.1% | 11/7/2022 | Target Lowered by | Chardan Capital | - | Buy | $188.00 -> $186.00 | Low | View details for Chardan Capital rating of Moderna (NASDAQ:MRNA) on 11/7/2022 |
GWH ESS Tech | $0.80 +5.3% | 11/4/2022 | Target Lowered by | Chardan Capital | - | Neutral | $5.00 -> $4.50 | Low | View details for Chardan Capital rating of ESS Tech (NYSE:GWH) on 11/4/2022 |
RGNX REGENXBIO | $15.80 +0.4% | 11/4/2022 | Target Lowered by | Chardan Capital | - | Buy | $70.00 -> $61.00 | Low | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 11/4/2022 |
NTLA Intellia Therapeutics | $25.73 +1.2% | 11/3/2022 | Target Lowered by | Chardan Capital | Analyst Geulah Livshits | Buy | $146.00 -> $121.00 | Low | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/3/2022 |
EDIT Editas Medicine | $5.68 -0.5% | 11/2/2022 | Target Lowered by | Chardan Capital | - | Buy | $60.00 -> $43.00 | Low | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 11/2/2022 |